JPRN-UMIN000003913已完成2 期
Randomized Controlled Trial of Rabeprazol Versus Placebo Administration in the Prevention of Esophageal Variceal Bleeding After Esophageal Variceal Ligation - POST-EVL Study
Post-EVL Study Office0 个研究点目标入组 44 人开始时间: 2010年7月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Hepatocellular carcinoma (2)Refractory ascites and uncontrolled hepatic encephalopathy (3)Active alcoholism before 3 months (4)Portal thrombus (5)Allergy or past adverse reaction to proton pump inhibitors
研究者
相似试验
已完成
不适用
A Randomized Controlled Trial Comparing Rabeprazol with Esomeprazol in the Treatment of Post-Endoscopic Submucosal Dissection Gastric UlcersJPRN-UMIN000024002Aso Iizuka Hospital Department of Gastroenterology60
未知
3 期
Randomized control trial of Rabeprazole for prevention of aspirin-associated ulcersAspirin-associated ulcersJPRN-UMIN000000853niversity of Tokyo, Department of Gastroenterology100
已完成
3 期
Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.HeartburnGastroesophageal RefluxNCT00553449Janssen-Ortho Inc., Canada48
进行中（未招募）
1 期
Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With RabeprazoleEUCTR2016-001879-73-Outside-EU/EEAEisai Medical Research Inc.111
已完成
不适用
Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese PatientsLaryngitisGastroesophageal RefluxNCT00517114Hospital Authority, Hong Kong200